Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2329770114;70115;70116 chr2:178576243;178576242;178576241chr2:179440970;179440969;179440968
N2AB2165665191;65192;65193 chr2:178576243;178576242;178576241chr2:179440970;179440969;179440968
N2A2072962410;62411;62412 chr2:178576243;178576242;178576241chr2:179440970;179440969;179440968
N2B1423242919;42920;42921 chr2:178576243;178576242;178576241chr2:179440970;179440969;179440968
Novex-11435743294;43295;43296 chr2:178576243;178576242;178576241chr2:179440970;179440969;179440968
Novex-21442443495;43496;43497 chr2:178576243;178576242;178576241chr2:179440970;179440969;179440968
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: R
  • RefSeq wild type transcript codon: AGA
  • RefSeq wild type template codon: TCT
  • Domain: Fn3-57
  • Domain position: 58
  • Structural Position: 83
  • Q(SASA): 0.7311
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
R/G rs779474257 -0.244 0.822 N 0.467 0.291 0.355450299083 gnomAD-2.1.1 4.05E-06 None None None None I None 0 0 None 0 0 None 0 None 0 8.98E-06 0
R/G rs779474257 -0.244 0.822 N 0.467 0.291 0.355450299083 gnomAD-4.0.0 2.05418E-06 None None None None I None 0 0 None 0 0 None 0 0 2.69949E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
R/A 0.6127 likely_pathogenic 0.6044 pathogenic -0.029 Destabilizing 0.754 D 0.503 neutral None None None None I
R/C 0.2693 likely_benign 0.2613 benign -0.238 Destabilizing 0.998 D 0.616 neutral None None None None I
R/D 0.8257 likely_pathogenic 0.8178 pathogenic -0.104 Destabilizing 0.956 D 0.503 neutral None None None None I
R/E 0.5863 likely_pathogenic 0.5748 pathogenic -0.054 Destabilizing 0.754 D 0.509 neutral None None None None I
R/F 0.7565 likely_pathogenic 0.7447 pathogenic -0.305 Destabilizing 0.993 D 0.593 neutral None None None None I
R/G 0.4401 ambiguous 0.4372 ambiguous -0.196 Destabilizing 0.822 D 0.467 neutral N 0.489823268 None None I
R/H 0.1498 likely_benign 0.1542 benign -0.621 Destabilizing 0.978 D 0.562 neutral None None None None I
R/I 0.4842 ambiguous 0.4974 ambiguous 0.369 Stabilizing 0.97 D 0.593 neutral N 0.486778739 None None I
R/K 0.1408 likely_benign 0.1523 benign -0.117 Destabilizing 0.006 N 0.177 neutral N 0.442509324 None None I
R/L 0.3885 ambiguous 0.3817 ambiguous 0.369 Stabilizing 0.86 D 0.467 neutral None None None None I
R/M 0.435 ambiguous 0.4614 ambiguous -0.022 Destabilizing 0.998 D 0.561 neutral None None None None I
R/N 0.7206 likely_pathogenic 0.7151 pathogenic 0.068 Stabilizing 0.956 D 0.507 neutral None None None None I
R/P 0.6182 likely_pathogenic 0.6142 pathogenic 0.255 Stabilizing 0.978 D 0.568 neutral None None None None I
R/Q 0.1514 likely_benign 0.1547 benign -0.031 Destabilizing 0.956 D 0.529 neutral None None None None I
R/S 0.7053 likely_pathogenic 0.7059 pathogenic -0.262 Destabilizing 0.822 D 0.515 neutral N 0.478816841 None None I
R/T 0.4452 ambiguous 0.4522 ambiguous -0.089 Destabilizing 0.822 D 0.499 neutral N 0.472602944 None None I
R/V 0.5466 ambiguous 0.5497 ambiguous 0.255 Stabilizing 0.956 D 0.585 neutral None None None None I
R/W 0.2988 likely_benign 0.2854 benign -0.391 Destabilizing 0.998 D 0.652 neutral None None None None I
R/Y 0.5684 likely_pathogenic 0.5523 ambiguous 0.019 Stabilizing 0.993 D 0.567 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.